Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.
Ilana Cass, MD
Concerns have been raised about the safety of GBCA. Experts review the latest data to support counseling of patients who may have repeated exposure.
An examination of ACOG’s updated guidelines on breast cancer screening recommendations for the average-risk woman.
Randomized controlled trials have established that mammography reduces breast cancer mortality. However, mammography is less effective in women with dense breasts.